u-card-img-1
News
Cell Reports

Researchers from GIGA-Cancer demonstrates the efficacy of a natural molecule for the treatment of colon cancer resistant to targeted therapy.  

Research work of Akeila Bellahcène (GIGA-Cancer, ULiège) identifies a natural molecule, the carnosine, produced by our body, taht lifts the resistance of colon cancer cells to targeted therapy.

Learn more
u-card-img-1
News
Awards

Francesca Rapino, prizewinner of the "Foundation against cancer"  

Francesca wons this mandate to study the role of the enzymes that modify tRNA in the antitumor response mediated by the immune system.

Learn more
u-card-img-1
News
GIGA-Cancer

Discovery of a key element in pancreatic cancer spreading - TGFBI  

Dr. Brunella Costanza from Olivier Peulen's group at the Metastasis Research Laboratory (LRM, GIGA-Cancer) discovers that TGFBI produced by pancreatic cancer cells controls their metastatic dissemination by modulating energy metabolism.

 

Learn more
u-card-img-1
News
GIGA-Cancer

Glycant stress highlighted in breast cancer cells  

The gene expression signature identified by the group of A. Bellahcene (LRM) at breast cancer cells makes it possible to highlight the glycemic stress and to propose a new therapeutic modality potentially applicable to different cancers.

Learn more
u-card-img-1
News
GIGA-Cancer

Myoferlin protects colon cancer cells from cell death  

Multimodal chemotherapy could be considered in patients with this cancer thanks to this discovery from Olivier Peulen's group (LRM, GIAG-Cancer).

 

Learn more
u-card-img-1
News
GIGA-Cancer

A new combination therapy to inhibit the growth of 50% of triple-negative breast cancers  

This work of Dr. Nor Eddine Sounni's team (GIGA-Cancer) has just been published in Clinical Cancer Research.

 

Learn more
u-card-img-1
News
GIGA-Cancer

Discovery of a molecule that can regulate the formation of lymphatic vessels  

This important advance for the treatment of cancers discovered by the team of Pr. Agnès Noël (GIGA-Cancer) has just been published in the prestigious journal Nature Communications.

Learn more
u-card-img-1
News
Research

“World HTLV Day” 10 November: raising awareness of HTLV-1 infection  

This day is an opportunity to raise public awareness of this under-researched virus, human T cell Leukemia Virus type 1 (HTLV-1) on which are working 3 teams at GIGA.

Learn more
u-card-img-1
News
GIGA-Cancer

Immunity and cancer : new breakthroughs through epigenetics  

Researchers from ULB and ULiège (GIGA-Cancer) are making progress in understanding the interaction between immune cells and cancer cells, via the deregulation of the epigenetic machinery. Their study is published in the journal Science Advances.

Learn more
u-card-img-1
News
GIGA-Cancer

Myoferline, a potential target in the treatment of pancreatic cancer  

Olivier Peulen's group (Metastasis Research Laboratory) shows that inhibition of myoferline may limit resistance to chemotherapy by modifying the metabolism of pancreatic malignant cells in patients with this cancer.

Learn more

Share this page